Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в травні 1995 (uk)
- article scientifique publié en 1995 (fr)
- im Mai 1995 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en mayu de 1995 (ast)
- scientific article published on 01 May 1995 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Hirano T
- Shimizu N
- Saito T
- Inoue T
- Tanaka K
- Endo K
- Tomiyoshi K
- Ootake H
|
rdfs:label
| - [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (en)
- [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (nl)
|
skos:prefLabel
| - [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (en)
- [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (nl)
|
name
| - [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (en)
- [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (nl)
|
title
| |
title
| - [Clinical evaluation of safety, pharmacokinetics and dosimetry of the somatostatin analog 111In-DTPA-D-Phe-octreotide--report of the phase 1 study] (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
is about
of | |
is cites work
of | |
is cites work
of | |